Browse grants

National Institutes of Health · Amount varies

This is a forecasted (not yet open) NIH opportunity to operate Statistical and Data Management Centers for the HIV/AIDS Clinical Trials Networks. It is intended for research institutions with strong biostatistics and clinical data management capacity. Eligibility, funding amounts, and deadlines have not yet been posted, and these large coordinating-center awards are typically substantial; interested applicants should watch for the full announcement.

National Institutes of Health · Amount varies

This is a forecasted (not yet open) NIH funding opportunity focused on how environmental exposures (the exposome) contribute to Alzheimer's disease and related dementias pathology and resilience. It is research-oriented and would typically suit universities, research institutions, and scientists with relevant expertise. Eligibility, funding amounts, and deadlines have not yet been published, so applicants should monitor for the full announcement.

Food and Drug Administration · Amount varies

This is a forecasted (not yet open) FDA R13 grant to support conferences and scientific meetings related to FDA's mission; clinical trials are not allowed. Such awards typically go to nonprofit and academic organizations that host relevant scientific gatherings and are usually modest in size. Eligibility details, funding amounts, and deadlines have not yet been posted, so interested applicants should watch for the full announcement.

National Institutes of Health · Amount varies

This is a forecasted (not yet open) NIH/National Library of Medicine opportunity to operate Regional Medical Libraries within the Network of the National Library of Medicine; clinical trials are not allowed under this UG4 mechanism. It is intended for institutions such as academic medical or research libraries with the capacity to serve a region. Eligibility details, funding amounts, and deadlines have not been published yet, so interested applicants should watch for the full announcement.

National Institutes of Health · Amount varies

This is a forecasted (not yet open) NIH opportunity supporting the Infectious Diseases Clinical Trials Network (IDCTN). It is intended for research institutions and academic medical centers with infectious-disease clinical trial capacity. Eligibility, funding amounts, and deadlines have not yet been posted, so interested applicants should monitor for the full announcement.

Administration for Children & Families - ACYF/FYSB · Amount varies

This is a forecasted (not yet open) Administration for Children & Families opportunity, the Competitive Personal Responsibility Education Program (PREP), which funds programs educating youth on pregnancy prevention, abstinence, and related life skills. It typically suits nonprofits, states, tribes, and community or education organizations serving youth. Eligibility, funding amounts, and deadlines have not yet been posted, so interested applicants should monitor for the full announcement.

National Institutes of Health · Amount varies

This is a forecasted (not yet open) NIH Director's Transformative Research Award (R01, clinical trial optional), supporting bold, unconventional research with potential for major scientific impact. These awards typically go to investigators at universities and research institutions and can be large. Eligibility specifics, funding amounts, and deadlines have not yet been posted, so applicants should monitor for the full announcement.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health program (ALACRITY Research Centers) supporting research centers that accelerate the development and real-world delivery of effective treatments for youth and adults with mental illness. These center awards typically fund universities and research institutions with established mental health research infrastructure and interdisciplinary teams. Detailed eligibility, funding amounts, and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health resource-access opportunity (X01) providing investigators with access to the Center for Inherited Disease Research (CIDR) for high-throughput sequencing and genotyping; clinical trials are not allowed. Rather than providing cash funding, it grants approved researchers access to a sequencing and genotyping resource, and applicants are typically investigators at research institutions. Eligibility, deadlines, and award details have not yet been published for this cycle.

Office of the National Coordinator · Amount varies

This is a forecasted Leading Edge Acceleration Projects for Health IT (LEAP) opportunity from the Office of the National Coordinator, which funds development of innovative health information technology to address emerging needs in health data exchange and use. Such awards typically go to organizations with health IT research and development capacity, such as universities, nonprofits, and companies. Eligibility, funding amounts, and deadlines have not yet been published for this cycle.

Health Resources and Services Administration · Amount varies

This is a forecasted Health Resources and Services Administration program, Scholarships for Disadvantaged Students (SDS), which provides funding to eligible health professions and nursing schools to award scholarships to financially or educationally disadvantaged students. Awards go to qualifying educational institutions that then distribute scholarships, not directly to individual students. Specific eligibility, funding amounts, and deadlines have not yet been published for this cycle.

Administration for Community Living · Amount varies

This is a forecasted Administration for Community Living program to scale evidence-based falls prevention programs, which typically support organizations that deliver proven community programs reducing fall risk among older adults. Eligibility, funding amounts, and deadlines have not yet been published, so applicants should watch for the official notice. ACL grants of this type usually go to nonprofits, state and tribal agencies, universities, and aging-services networks rather than individuals.

Centers for Disease Control-GHC · Amount varies

This is a forecasted Centers for Disease Control (Global Health Center) cooperative agreement to strengthen global health security by improving public health capacity to detect, notify, and respond to disease outbreaks worldwide. Such awards typically go to organizations with international public health implementation experience, such as nonprofits, NGOs, universities, and foreign or multinational health entities, and are global in scope. Eligibility, funding amounts, and deadlines have not yet been published for this cycle.

Food and Drug Administration · Amount varies

This is a forecasted U.S. Food and Drug Administration cooperative agreement (U01) supporting research into the synthesis and biological activity of different diastereomers of the siRNA drug LEQVIO (inclisiran); clinical trials are not allowed under this opportunity. It is a highly specialized research award aimed at institutions and laboratories with relevant chemistry and pharmacology capabilities. Eligibility, funding amounts, and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Eye Institute (NIH) New Innovator Award (DP2) supporting early-stage investigators pursuing high-risk, high-reward vision research; clinical trials are not allowed. These awards are made to institutions on behalf of eligible early-career researchers who meet specific career-stage criteria, making them narrowly targeted. Funding amounts and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health Medical Scientist Training Program (MSTP), which supports integrated MD-PhD dual-degree training to develop physician-scientists. Such awards are made to eligible U.S. degree-granting institutions (typically medical schools), not to individual students directly, and require an established training infrastructure. Specific eligibility, funding amounts, and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health research opportunity focused on advancing screening, diagnosis, and referral for late-talking children. Such awards typically fund researchers at universities, hospitals, and research institutions rather than individuals or service providers. Detailed eligibility, funding amounts, and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health Native American Research Centers for Health (NARCH) program, which supports partnerships between American Indian/Alaska Native tribes or tribal organizations and research institutions to build health research capacity and address tribal health priorities. Eligibility is typically restricted to federally recognized tribes, tribal organizations, and inter-tribal consortia (sometimes with academic partners), making it narrowly targeted. Funding amounts and deadlines have not yet been published for this cycle.

Centers for Disease Control-GHC · Amount varies

This is a forecasted Centers for Disease Control (Global Health Center) cooperative agreement to improve regional capacity to respond to HIV, tuberculosis, and other global health priorities in Central America. Such awards typically go to organizations with regional public health implementation experience, such as nonprofits, NGOs, universities, and regional or foreign health entities, and are geographically focused on Central America. Eligibility, funding amounts, and deadlines have not yet been published for this cycle.

National Institutes of Health · Amount varies

This is a forecasted National Institutes of Health research opportunity supporting a holistic study of non-addictive natural products for pain management. Such awards typically fund researchers at universities, research institutions, and laboratories investigating new pain therapies. Detailed eligibility, funding amounts, and deadlines have not yet been published for this cycle.